Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

Harshita Chodavarapu; Nadja Grobe; Hari K. Somineni; Esam S.B. Salem; Malav Madhu; Khalid M. Elased

doi:10.1371/journal.pone.0062833

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

Harshita Chodavarapu, Nadja Grobe, Hari K. Somineni, Esam S.B. Salem, Malav Madhu, Khalid M. Elased

Wright State University

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e62833
Journal	PLoS ONE
Volume	8
Issue number	4
DOIs	https://doi.org/10.1371/journal.pone.0062833
State	Published - Apr 30 2013

ASJC Scopus Subject Areas

General

Disciplines

Chemicals and Drugs
Medical Toxicology
Medicine and Health Sciences

Access to Document

10.1371/journal.pone.0062833

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice AttenuatesFinal published version, 3.94 MBLicense: Unspecified

Cite this

@article{90cf131ed151486da760266535246e91,

title = "Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion",

author = "Harshita Chodavarapu and Nadja Grobe and Somineni, {Hari K.} and Salem, {Esam S.B.} and Malav Madhu and Elased, {Khalid M.}",

note = "Chodavarapu, H., Grobe, N., Somineni, H. K., Salem, E. S. B., Madhu, M., & Elased, K. M. (2013). Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion. PLoS ONE, 8(4), e62833. http://doi.org/10.1371/journal.pone.0062833",

year = "2013",

month = apr,

day = "30",

doi = "10.1371/journal.pone.0062833",

language = "English",

volume = "8",

journal = "PLoS ONE",

issn = "1932-6203",

number = "4",

}

TY - JOUR

T1 - Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

AU - Chodavarapu, Harshita

AU - Grobe, Nadja

AU - Somineni, Hari K.

AU - Salem, Esam S.B.

AU - Madhu, Malav

AU - Elased, Khalid M.

N1 - Chodavarapu, H., Grobe, N., Somineni, H. K., Salem, E. S. B., Madhu, M., & Elased, K. M. (2013). Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion. PLoS ONE, 8(4), e62833. http://doi.org/10.1371/journal.pone.0062833

PY - 2013/4/30

Y1 - 2013/4/30

UR - http://www.scopus.com/inward/record.url?scp=84876981345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876981345&partnerID=8YFLogxK

UR - https://corescholar.libraries.wright.edu/ptox/112

U2 - 10.1371/journal.pone.0062833

DO - 10.1371/journal.pone.0062833

M3 - Article

C2 - 23646149

AN - SCOPUS:84876981345

SN - 1932-6203

VL - 8

JO - PLoS ONE

JF - PLoS ONE

IS - 4

M1 - e62833

ER -

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

ASJC Scopus Subject Areas

Disciplines

Access to Document

Other files and links

Cite this